Ligand profile
SUY
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: KP13_00051 — DNA gyrase subunit B
Identifiers
Database identifiers and provenance.
- Ligand ID
SUY- PDB
4gfn- UniProt (similar protein)
Q839Z1- Target protein
- KP13_00051
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 96.6
- −1 ≤ LogP ≤ 5 2.51
- MW ≤ 500 Da 387.9
- LogP ≤ 5 2.51
- H-bond donors ≤ 5 2
- H-bond acceptors ≤ 10 7
- Rotatable bonds ≤ 10 4
- TPSA ≤ 140 Ų 96.6
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
CCc1c(c2c([nH]1)nc(nc2N3C[C@@H]4[C@H](C3)C4N)Sc5cncnc5)ClCCc1c(c2c([nH]1)nc(nc2N3C[C@@H]4[C@H](C3)C4N)Sc5cncnc5)Cl
InChI=1S/C17H18ClN7S/c1-2-11-13(18)12-15(22-11)23-17(26-8-3-20-7-21-4-8)24-16(12)25-5-9-10(6-25)14(9)19/h3-4,7,9-10,14H,2,5-6,19H2,1H3,(H,22,23,24)/t9-,10+,14?InChI=1S/C17H18ClN7S/c1-2-11-13(18)12-15(22-11)23-17(26-8-3-20-7-21-4-8)24-16(12)25-5-9-10(6-25)14(9)19/h3-4,7,9-10,14H,2,5-6,19H2,1H3,(H,22,23,24)/t9-,10+,14?
OOKWYXHTSPTWDS-XFLKPENQSA-NOOKWYXHTSPTWDS-XFLKPENQSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF02518
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand SUY →
- PDB RCSB structure 4gfn →
- UniProt UniProt Q839Z1 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “SUY”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_00051.
PDB 87
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 100
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).